chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 adverse events occurred:  1. First adverse event: On 12/10/21 noticed lymph nodes under the right armpit (injection arm) were swollen . They stayed swollen for 4 days (12/10/21-12/13/21).  2. Second adverse event: On  12/14/21 developed red swollen itchy rash under both armpits. Throughout the next few days rash progressed further involving front of the groin area, the butt cheeks, back of both knees, both inner bicep area,  lower back, base of the neck , both elbows, and underside of both forearms. As of report date 12/17/21 rash is still present and continues to be red and itchy.
I sat for 15 min and not symptoms. About 3 or 4 hours later I was tired and had achy joints. The next morning I had a fever that maxed at 100.7.  I experienced pain in my shoulders, hips and knees. I was fine the next day. I didn't have to actually get treatment, but I did have to get tested for COVID again before I could return to work.
Swollen facial/lip,, very painful arm, feeling disoriented, severe trouble breathing, very tired, fever/chills,headache  My left arm became very painful immediately after injection(the injection didn't hurt,it was after needle removed & she was getting bandage), then I started to feel lightheaded & disoriented and trouble breathing and Blood pressure elevated but it was very low immediately after injection. Didn't start feeling well until  more than 2 wks after shot.
Redness at injection site. Painful to touch at injection site. Also raised bump at injection site. Only noticed this tonight.
On December 18th got an itchy rash on scalp, neck, throat, back and chest. Took 50 mg Benadryl On December 19th started getting patchy, scaly hives on forearms. That night was experiencing rashes and hives appearing and disappearing all over my body On December 20th woke up with eyes swollen almost shut, ears swollen and body was covered in angry hives and pinprick rashes. Knees had little hives on them and skin on knees, elbows and butt was tender and felt blistery (but no actual blisters). Went to Urgent care and got a steroid cream. The Dr told me to take 180 mg of Allegra twice a day and Benadryl at night.  On December 21st have eczema like patches on hands, eyes and arms and a rash on chest and stomach. Benadryl seems to help the most but Allegra is helping too.
2 days after vaccine administration. Swollen upper lip with a fever blister; 2 days after vaccine administration. Swollen upper lip with a fever blister; This is a spontaneous report from a contactable consumer (patient).   A 65-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EN6209), via an unspecified route of administration in the Arm right on 23Feb2021 at 13:45, as a single dose for COVID-19 immunisation. The patient allergic to penicillin, macrodantin and morphine. The patient's concomitant medications included verapamil hydrochloride (VERAPAMIL [VERAPAMIL HYDROCHLORIDE]) 180 mg for unspecified indication (start and stop date were not reported).  Historical vaccination included Flu shot and Pneumonia shot in the Right arm on 29 Jan 2021. The patient did not test for COVID-19 after vaccination. On 25Feb2021 at 06:00, the patient experienced 2 days after vaccine administration swollen upper lip with a fever blister. The patient did not receive any treatment for the events. All the events were non-serious. The outcome of all the events was recovered on an unspecified date in 2021.    No follow-up attempts are possible. No further information is expected.
Myalgia, Fever, neck and jaw pain, injection site tenderness Narrative: missed a day of work
Very blurry vision, headache, nausea, dizziness, mild confusion (feeling air-headed)
This spontaneous report as received from a pharmacist refers to a 70 year old male patient. The patient's pertinent medical history and drug allergies/reactions were unspecified by reporter. On 20-NOV-2014 the patient was vaccinated with 0.5ml dose of PNEUMOVAX 23 (lot # K009874, expiration date 19-MAR-2016), intramuscular in the left arm. The patient called in to the pharmacy on 21-NOV-2014, stated that at 11 pm last night (on 20-NOV-2014) his left arm went numb and he had pain from his left shoulder all the way down to the tips of his fingers. The patient went to an unspecified Emergency Room (on 20-NOV-2014) and "they didn't do anything for him, just discharged him at 6 am this morning (on 21-NOV-2014)". No treatment was given for the event. The pharmacist stated "the patient told me today (on 21-NOV-2014) that he can't move his left arm over his head". The outcome of the events was reported as not recovered. Additional information has been requested.
On 3/26/2021, I noticed my arm was itching around the injection site. I had a small, hard bump where the shot was given that was about the size of a pea. And my arm was hot and red. It?s been 3 days since I first noticed the symptoms and my arm still has a red rash about 2 inches below the injection site. The rash feels warm but the bump is gone. I haven?t gone to the doctor or anything because it?s not that bad but thought I should report it.
Pt complained of flu-like symptoms including stomach ache, bloated, headache, dehydrate, stomach pains and fever.
Axillary lymph node tenderness under right arm @ 6 days after first vaccine injection; in right arm.  Swollen and warm at injection site on right arm @ 8 days after first vaccine injection; in right arm.
Initial report received on 19 March 2009 from a consumer who is the patient's parent. A male patient had received DTaP when he was an infant (manufacturer, lot number, route/site and date of administration not reported) and an unspecified amount of time later (reported as "approximately 1985 - 1986"), he experienced a seizure, serious fever, breathing (type of breathing not reported) and a rash. According to the reporter, the primary care provider documented from 1985 - 1986 that the patient could not tolerate the Pertussis vaccine and "gave prt doses" due to the reported event. The reporter further reported that their niece experienced serious seizures following DTP vaccination (captured in case 2009-01150). No additional information was provided at the time of the report. The reporter for this case is the same as for case numbers 2009-00841 and 2009-01150.
This case was reported by a physician and described the occurrence of diarrhea in a 4-month-old female who was vaccinated with ROTARIX. Concurrent vaccinated included poliomyelitis vaccine inactivated (non-gsk); non-GSK manufacturer; unknown; unknown given on 13 May 2013. Concurrent medications included ZANTAC and ORAJEL. On 13 May 2013 the subject received 1st dose of ROTARIS (1 ml, oral). On 14 May 2013, 1 day after vaccination with ROTARIX, the subject experienced diarrhea. A physician reported a 4-month old patient was vaccinated with ROTARIX and developed diarrhea. The subject had two episodes on 14 May 2013 and five episodes on 15 May 2013. At the time of reporting the event was unresolved.
Shot improperly administered, resulted in blood spurting, bruised area. Arm and shoulder stiffness persists.
Patient's husband alerted pharmacy staff that patient was having difficulty breathing with bright red pallor roughly 5 minutes following her second dose. She was slightly hyperventilating, had pain radiating from her neck superior to her ears and anterior down her back. She described the pain as "shooting" and moving downward. She was able to take deep breaths and converse with no issues so epinephrine was not administered. Paramedics were called to the scene to assess her condition. She was able to stand, showed no signs of dizziness or change in mental status, and her pallor began returning to baseline. EMS took her BP and oxygenation, she declined transport to a hospital and remained at the pharmacy for an extra 30 minutes.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 at 17:30 as dose 5 (booster), single (Lot number: gh9694) at the age of 61 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ATENOLOL, start date: 01Oct2014, stop date: 12Oct2022. Past drug history included: Tetracycline, reaction(s): "Known allergies: tetracycline", notes: Known allergies: tetracycline. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2, BNT162B2 OMI BA.4-5 to the reported drug ineffective / COVID-19 cannot be ruled out
earache/ear infection; earache/ear infection; fever; chills; headache; bodyaches; This is a spontaneous report from a contactable consumer or other non hcp. A 50-year-old non-pregnant female patient received second dose of BNT162B2 (BNT162B2, solution for injection, Batch/Lot Number: EN6205), via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 (at the age of 50-year-old) as single dose for covid-19 immunisation. Medical history included renal transplant (Kidney Transplant) from 2018 to an unknown date. Concomitant medication(s) included prednisone (PREDNISONE); tacrolimus (TACROLIMUS); mycophenolate mofetil (MYCOPHENOLATE); omeprazole (OMEPRAZOLE). The patient had no known allergies. The patient did not take any other vaccines within four weeks, prior to covid-19 vaccination. Patient was not tested positive for covid-19 prior to vaccination. Patient done covid test post vaccination. The patient previously took BNT162B2 (BNT162B2, solution for injection), via an unspecified route of administration, on an unknown date as 1st dose, single for covid-19 immunisation. On 14Mar2021, the patient experienced earache/ear infection, fever, chills, headache, bodyaches. The patient adverse events includes Side effects (fever, chills, headache, earache/ear infection, and bodyaches) didn't occur until 14Mar2021. Patient was informed by her physician to report this as paperwork she received indicated possible side effects up to 72 hours. Adverse events resulted in Emergency room/department or urgent care. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal Swab): pending on 15Mar2021. Therapeutic measures were taken as a result of earache/ear infection included antibiotics. The outcome of the events were not recovered.   No follow-up attempts are possible. No further information is expected.
Immediately after vaccine patient stood up and became dizzy and passed out. B/P 95/61 at 6:02 had patient lay down and gave crackers and juice. B/P 101/65 at 6:39. Patient was feeling better and left with significant other
Patient is a 73 year old female past medical history of hyperlipidemia, GERD, anxiety and tested positive for COVID 19 on 08/10/2021.  She was brought to the emergency department earlier today by her husband for evaluation of chest pain, shortness of breath, headache and left-sided weakness that started approximately 1 hour prior to arrival.  Initial CT head negative for any acute intracranial abnormality or evidence of large vessel occlusion.  CTA was obtained to rule out aortic dissection in setting of chest pain and shortness of breath, result negative. Stroke alert was activated she was evaluated by tele neurologist who recommended IV alteplase.   Tested positive on 9/13/2021. Patient is a 73 year old female past medical history of hyperlipidemia, GERD, anxiety and tested positive for COVID 19 on 08/10/2021.  She was brought to the emergency department earlier today by her husband for evaluation of chest pain, shortness of breath, headache and left-sided weakness that started approximately 1 hour prior to arrival.  Initial CT head negative for any acute intracranial abnormality or evidence of large vessel occlusion.  CTA was obtained to rule out aortic dissection in setting of chest pain and shortness of breath, result negative. Stroke alert was activated she was evaluated by tele neurologist who recommended IV alteplase. IV tPA bolus given at 12:45 and infusion complete at 13:55. After IV tPA infusion patient developed worsening headache symptoms. CTA head/neck and perfusion studies were subsequently obtained, negative for any acute occlusion or hemorrhage. CCM was consulted to evaluate patient for ICU admission for close neurological checks post thrombolytic therapy. I personally evaluated patient in ED room. She is awake, alert, oriented to person and place, in no apparent respiratory distress. Hemodynamically stable. IV tPA infusion complete. She is complaining of headache 6/10,  confusion and states she feels uncoordinated. Reports that her weakness has improved. Denies any visual disturbances or paraesthesias.
Feverish and shitty and headachey. I had to fly home instead of continuing on with my vacation.
Information was received from a registered nurse and a physician concerning a 6 year old white male who on 01/08/01 was  vaccinated SC in the right arm with a 1st dose of Varicella virus live. There was no illness at the time of vaccination. There were no concomitant medications reported. On approximately 01/17/01, the father of the patient reported to the physician's office that he noticed that his son had developed a "red, warm area, about the size of a quarter" at the injection site (right arm). On 01/19/01, the patient presented to the physician's office (also indicated by the physician as "no doctor visit") with a 5x5 cm erythema near the injection site, a 3x3 cm induration near the injection site. In follow-up the physician reported the child had developed "early cellulitis of the arm at the site of injection" on 01/19/01. The child was being treated with unspecified oral antibiotics. Upon internal review, signs of cellulitis, was determined to be an other important medical event. Follow-up information has been received that states the patient had cellulitis of the right upper arm that started on approximately 01/17/01 and lasted for one week. The patient was treated with oral antibiotics and the problem resolved. Additional information is not expected.
3 days after vaccine was administered , I developed debilitating pain on my lower back , right side. Extremely  Painful sitting down and rising from a seated position   His has been goin on for 2 days. I went to doctor today who prescribed  and striped pack.
Per parent child had high fever with lethargy and shaking. Called ambulance at 0100 in am. ER doctor gave fluids and medication that Mom doesn't remember were.
At approxiamtely 1716 observation nurse reported 37 year old male with no known allergies complaining of throat tightness and ?weird feeling in throat? after receiving Janssen vaccine ( Lot # 204A21A). Patient assessed, no visual swelling noted on evaluation. Patient denies difficulty breathing or difficulty swallowing. Vitals stable BP 108/65, HR 67, RR 17, O2 Sats 98% on room air. Patient was alert and oriented and in no visible distress. 1720- EMS already on scene for a different call and was called for further evaluation of this patient as well . 1724 EMS assessed patient. Pt stable and refuses transport. Patient states he "feels ok?. Patient educated to seek medical attention for any difficulty breathing, difficulty swallowing or any concerning symptoms. Pt discharged in stable condition.
Fussiness, nasal congestion, rhinorrhea started evening of 4/24/19. Fever & developing rash started 4/25/19. Cyanosis & coolness of feet noted last night.
About 9 hours after receiving the vaccine I experienced severe shivering for 20 - 30 minutes, almost to the point where my teeth chattered. I did not have a fever. I was in bed and covered by blankets. The ambient temperature was 63 degrees F. I moved a heating pad all around my body until the shivering stopped. The next day I felt really lousy all day, as if I were having chemotherapy all over again. I stayed in bed all day.
Pfizer-BioNTech COVID-19 Vaccine EUA  metallic taste, relieved after drinking water
Skin now blotchy and flaky; Welps all over body; Delayed Rash all over body; Felt dizzy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Delayed Rash all over body), DIZZINESS (Felt dizzy), RASH MACULAR (Skin now blotchy and flaky) and PRURITUS (Welps all over body) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Delayed Rash all over body), DIZZINESS (Felt dizzy) and PRURITUS (Welps all over body). On 22-Feb-2021, the patient experienced RASH MACULAR (Skin now blotchy and flaky). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency; TRIAMCINOLONE for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (Delayed Rash all over body), DIZZINESS (Felt dizzy), RASH MACULAR (Skin now blotchy and flaky) and PRURITUS (Welps all over body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not reported  Treatment : Steroid shot by primary care doctor
Shingles; active lesions.; is 48 years old but stated that he had a medical condition that warranted receiving Shingrix before age 50 therefore; is 48 years old but stated that he had a medical condition that warranted receiving Shingrix before age 50 therefore; if the patient was administered with Infanrix / inappropriate age at vaccine administration; This case was reported by a physician via call center representative and described the occurrence of shingles in a 48-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Hib (Hiberix) for prophylaxis, PNEUMOCOCCAL VACCINE (PREVNAR) for prophylaxis, DIPHTHERIA TOXOID + PERTUSSIS TOXOID + TETANUS TOXOID (DAPTACEL) for prophylaxis, POLIOMYELITIS VACCINE INACTIVATED (IPV VACCINE) for prophylaxis, DTPa (Infanrix) for prophylaxis and dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th December 2021, the patient received the 1st dose of Shingrix (intramuscular) 50 µg, Hiberix, PREVNAR, DAPTACEL, IPV VACCINE, Infanrix and Infanrix Pre-Filled Syringe Device. On 15th December 2021, unknown after receiving Shingrix and not applicable after receiving Hiberix, Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced off label use, drug use for unapproved indication and inappropriate age at vaccine administration. On 24th December 2021, the patient experienced shingles and skin lesion. On an unknown date, the outcome of the shingles and skin lesion were not recovered/not resolved and the outcome of the off label use, drug use for unapproved indication and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the shingles and skin lesion to be related to Shingrix, Hiberix, Infanrix and Infanrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter was the patient and he is also a medical doctor. The patient received doses of Shingirx, DTaP, HIB, IPV, and Prevnar and experienced shingles. The patient was 48 years old but stated that he had a medical condition that warranted receiving Shingrix , which led to off label use, drug use for unapproved indication.  On the same day the patient received DTaP, HIB and Infanrix , which led to inappropriate age at vaccine administration. The reporter stated that he thought the name of the DTaP vaccine he was administered was Daptacel.  The reporter did not provide lot or expiration date of the vaccines administered. The reporter stated that on 24th December 2021, approximately 10 days after the vaccines, he developed shingles which was currently unresolved. he still had active lesions. The reporter also stated that if the patient was administered Hiberix or Infanrix (exact vaccines administered uncertain per patient) then that would be AE for inappropriate age.  The reporter did not want to provide his email. The reporter consented to follow-up.
Large red rash around injection site on left upper arm.  Feels hot to the touch. First noticed 2 days after second dose. (In addition to headache and general fatigue starting 1 day after second dose)
Grandmother reports that the evening after vaccines were given baby had temperature of 104 degrees, stopped breathing and turned blue. They called 911 and baby is now on an apnea monitor when sleeping. Baby was found to have urinary tract infection at time of episode.
Shot received at 7p on 2/26/21 Large welt appeared at injection site, raised, red, hot, painful to touch and arm was very sore on 2/27/21 at approximately 4p.  Welt remained and became itchy over the course of the next week.  Welt was gone by 3/3/21 Welt returned and was very sore and itchy on 3/6/21 Applied hydrocortisone cream and took a zyrtec to relive itching 3/6/21-3/7/21 Welt was gone again by 3/11/21 Arm is still painful to raise to the side in the injection area as of 3/18/21
no additional adverse event reported; Caller is a medical assistant calling to report that an expired dose of ROTATEQ was administered to the patient on 26SEP2022. Caller reports that the dose of ROTATEQ expired on 17SEP2022 and did not experience a temperautre excursion. No additional i; This spontaneous report was received from a medical assistant and refers to a patient of unknown age.     On 26-SEP-2022, the patient was vaccinated with expired rotavirus vaccine, live, oral, pentavalent(ROTATEQ) l(ot # U011810 with expiration date 17-SEP-2022) for prophylaxis.(expired product administered).and did not experience a temperature excursion. No additional adverse event were reported.
Patient is fully vaccinated and boosted.  Tested COVID positive.  45-year-old male presenting to the ED for dizziness, lightheadedness, and multiple syncopal episodes.   Hypotensive and bradycardic on arrival. Positive for cough, fatigue, myalgias. BP 99/58  | Pulse 57  | Temp 97.3 °F (36.3 °C) (Oral)  | Resp 16  | Ht 180.3 cm (5' 11")  | Wt 113 kg (250 lb)  | SpO2 96% CT of head: no acute pathology. CXR: no acute process. Medications: fluids, rocephin, decadron. discharged home.